KnowGovRepresentation. Influence. Action.
BillHR 8205 · 119

Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026

Introduced
Apr 6, 2026
Cosponsors
75
Traction
0
Last Action
May 21, 2026

Bill Summary

Reauthorizes and funds a program to accelerate access to critical therapies for people with Amyotrophic Lateral Sclerosis (ALS). Extends existing research and treatment efforts for ALS patients.

Sponsored By

Mike Quigley
Democrat · Illinois · House

Bill Journey

  1. Apr 6, 2026
  3. May 21, 2026You Are Here

    The committee will review the bill, debate amendments, and vote on whether to advance it to the full chamber.

  4. TBD

    The full chamber debates the bill, may amend it, and votes on whether to pass it.

  5. TBD

    If passed by the first chamber, the other chamber considers, may amend, and votes on the bill.

  6. TBD

    If passed by both chambers, the bill goes to the President to sign into law or veto.

Why It Matters

This bill affects people with Amyotrophic Lateral Sclerosis (ALS) by potentially providing them with faster access to new and experimental treatments. It also impacts researchers and healthcare providers working on ALS therapies by providing continued funding for their work.

Impact Areas

Sample
Addresses Supply
Targets an underlying shortage driving costs.
Supports Families
Aimed at easing pressure on working households.
Long-term Impact
Effects compound across multiple budget cycles.
Expands Access
Lowers barriers for first-time participants.

Support & Opposition

Sponsor & cosponsor support by party
56backers
  • Democratic28
  • Republican28
Cross-party cosponsors28 · 51%

Documents

1

Full text opens on congress.gov, the official source.

Cosponsors (75)

Show all 51 more

20 more not shown here — see the full list on congress.gov.

Bill Details

Bill TypeHouse Bill · Federal
Primary TopicHealth
CommitteeHouse Committee (sample)Sample
IntroducedApr 6, 2026
Last UpdatedMay 21, 2026
Latest ActionOrdered to be Reported (Amended) by the Yeas and Nays: 46 - 0.
Subjects
  • Health

Summary and impact analysis written by Judy (KnowGov's enrichment AI). Bill metadata, status, sponsor, and any floor votes from Prism. Sections marked “Sample” are placeholders not yet connected to live data.